TrianglePUBLICATIONS · 22964882
The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results from the LRF AML14 and NCRI AML16 pick-a-winner comparison.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Leukemia
- Publication date
- 2013 Jan
- First author
- Burnett AK
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Burnett AK
- type
- Author
- name
- Hills RK
- type
- Author
- name
- Hunter AE
- type
- Author
- name
- Milligan D
- type
- Author
- name
- Kell WJ
- type
- Author
- name
- Wheatley K
- type
- Author
- name
- Yin J
- type
- Author
- name
- McMullin MF
- type
- Author
- name
- Dignum H
- type
- Author
- name
- Bowen D
- type
- Author
- name
- Russell NH
- type
- Author
- name
- UK National Cancer Research Institute AML Working Group
- type
- CollectiveName
Complete bibliographic record and source provenance
- authors
- name
- Burnett AK
- type
- Author
- name
- Hills RK
- type
- Author
- name
- Hunter AE
- type
- Author
- name
- Milligan D
- type
- Author
- name
- Kell WJ
- type
- Author
- name
- Wheatley K
- type
- Author
- name
- Yin J
- type
- Author
- name
- McMullin MF
- type
- Author
- name
- Dignum H
- type
- Author
- name
- Bowen D
- type
- Author
- name
- Russell NH
- type
- Author
- name
- UK National Cancer Research Institute AML Working Group
- type
- CollectiveName
- bibliography ids
- nci-bib-b5a12eb16f5c0d188525adf5
- book metadata
- content sha256
- de14992098009b9f05a1efa5074489c556b59aa8f24e862270390b099255f653
- document type
- citation
- dois
- 10.1038/leu.2012.229
- electronic publication date
- display
- 2012 Aug 14
- precision
- day
- year
- 2012
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:22964882
- immutable id
- pubmed:22964882@de14992098009b9f05a1efa5074489c556b59aa8f24e862270390b099255f653
- journal
- abbreviation
- Leukemia
- issn electronic
- 1476-5551
- issn print
- 0887-6924
- issue
- 1
- name
- Leukemia
- nlm unique id
- 8704895
- pages
- 75-81
- volume
- 27
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 22964882
- provenance
- batch id
- 1e3045de9f47a5ccd566
- provider
- NCBI PubMed ESummary
- record sha256
- 93d38913b1abd36958701006f3a70a1d39143727e6fb4a80af990e4101796fd9
- response sha256
- 0c42e87ee821aef9d804e2d77dfdba8876f375111db163986dd22ba43a3d6a52
- retrieved at
- 2026-09-09T23:46:50.128287+00:00
- publication date
- display
- 2013 Jan
- precision
- month
- year
- 2013
- publication types
- Comparative Study
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results from the LRF AML14 and NCRI AML16 pick-a-winner comparison.
Preserved source evidence · Not medical advice